Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
November 21, 2022
Science Says: The promise of precision medicine
How understanding unique traits of individuals and their cancers can lead to precise treatments
When more is more: Increased levels of wild-type and mutant RIT1 promote oncogenesis
From the Berger Lab, Human Biology Division
Science Says: Cracking the code in solid tumors
How scientists are developing targeted new therapies for cancers of the breast, lung, stomach and more
Seeking to expand targeted therapy for lung cancer
NIH MERIT Award will support Dr. Alice Berger’s efforts to target lung cancer-associated gene mutation
Tip Sheet: Latest research on COVID-19, health disparities, antibodies to parainfluenza, and neuron function
Summaries of recent Fred Hutch research findings and other news
New protocols, precision approaches ahead for lung cancer
Hutch researchers launch liquid biopsy study; large biomarker protocol publishes, providing ‘roadmap’ for treatment of metastatic patients
MYCN drives the development of chemoresistance in small cell lung cancer
From the MacPherson lab, Human Biology Division
Comparing sexual quality of life among survivors of prostate, bladder, colorectal, and lung cancer
From the Ramsey Group, Public Health Sciences Division
Lessons from cancer patients in the time of coronavirus
For the immunocompromised and those with disease, social distancing and uncertainty are a way of life. Daily walks, gratitude and dancing help.
Largest single-year drop in cancer death rates continues encouraging trend
Stat reflects decrease in deaths from top 4 cancers; masks lack of progress in others
Study links common immune cell to failure of checkpoint inhibitors in lung cancer
New research suggests how to better predict which patients will respond to immunotherapy
'Keeping these out of the hands of adolescents is critical'
Fred Hutch lung cancer expert testifies as Washington state weighs flavored vaping ban
New program to fast-track lung cancer research from lab to clinic
Patient-focused science at the heart of $13M National Cancer Institute grant
Breaking down HIV exclusions in cancer clinical trials
As an eligibility barrier cracks, a lung cancer patient gets a new lease on life
Artificial intelligence and cancer
New study tests ability of natural language processing to search lung cancer patients’ records for treatable mutations
Reducing the cancer burden for women around the globe
Dr. Nancy Davidson on improving outcomes for women with breast, lung and colorectal cancer
Blood clots: What cancer patients need to know
A common side effect of cancer and its treatment gets renewed attention and potential new therapies
Q&A: A new focus on small cell lung cancer
Dr. David MacPherson discusses the state of small cell lung cancer research, how his lab is tackling this deadly disease, and what makes him excited for the future
Exploring why people with HIV have a higher lung cancer risk
120 volunteers to enroll in Seattle-area study of cancer-related gene mutations